Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genetic Technologies Ltd | GENE | NASDAQ | Depository Receipt |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0205 | -1.11% | 1.8295 | 1.85 | 1.8044 | 1.85 | 1.85 | 11:38:14 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.73 | 1.83 | 0.10 | 5.46% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume |
|---|---|---|---|---|
| 15 | 5,957 | 1.82 | 10,839 | 37,633 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:32:14 | 37 | 1.7505 | USD |
Genetic Technologies Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | |
|---|---|---|---|---|---|
| 8.96M | 4.90M | -5.46M | -0.98 | - | 4.90M |
| Dividends Per Share | Dividend Yield | ||||
|---|---|---|---|---|---|
| - | - | 0.00% | - | - |
News Genetic Technologies
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
GENE Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0 | 0 | 0 | 0.0000 | - | - | - |
| 1 Month | 0 | 0 | 0 | 0.0000 | - | - | - |
| 3 Months | 0 | 0 | 0 | 0.0000 | - | - | - |
| 6 Months | 0 | 0 | 0 | 0.0000 | - | - | - |
| 1 Year | 0 | 0 | 0 | 0.0000 | - | - | - |
| 3 Years | 0 | 0 | 0 | 0.0000 | - | - | - |
| 5 Years | 0 | 0 | 0 | 0.0000 | - | - | - |
| Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. |
